SCHEMBL168065

SCHEMBL168065

CCCCCCC(CC(O)CO)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.62
GRIK2 Q13002 2/20 0.62
SLC1A2 P43004 2/20 0.59
SLC1A1 P43005 2/20 0.59
GPR84 Q9NQS5 7/20 0.53
FFAR1 O14842 2/20 0.53
SLC1A3 P43003 1/20 0.51
CA2 P00918 2/20 0.50
MAPK1 P28482 1/20 0.50
FFAR4 Q5NUL3 1/20 0.49
MAPT P10636 1/20 0.47
LCK P06239 1/20 0.47
PPARD Q03181 1/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.47
ZDHHC2 Q9UIJ5 1/20 0.47
ACE2 Q9BYF1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL425590 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL28996904 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL167223 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
Dodecane SCHEMBL1325927 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL1237976 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL23854065 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL165538 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL17646228 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL1512830 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL4962689 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 825 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4034091-B1 RIFAXIMIN LIQUID FORMULATIONS BAUSCH HEALTH IRELAND LTD (IE) 2026-05-20 EP claimed
EP-4065069-B1 HAIR CONDITIONER COMPOSITIONS CONTAINING BEHENAMIDOPROPYL DIMETHYLAMINE PROCTER & GAMBLE (US) 2026-03-11 EP claimed
EP-4554551-B1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS SYMRISE AG (DE) 2026-03-11 EP claimed
EP-4514308-B1 INVERSE EMULSION COMPRISING A POLYPHENOL, A NON-IONIC POLYSACCHARIDE, A POLYGLYCEROLATED NON-IONIC SURFACTANT WITH AN HLB < 8, A POLYOL, A NON-VOLATILE PLANT OIL, AND A VOLATILE ALKANE OREAL (FR) 2026-03-04 EP claimed
WO-2025229079-A1 USE OF COMPOSITIONS CONTAINING 2-ETHYLHEXYL LAURATE FOR TREATING ECTOPARASITES G. POHL-BOSKAMP GMBH & CO. KG (DE) 2025-11-06 WO claimed
EP-3226919-B1 NEUTRALIZATION OF ODORS SADOVSKY LTD (IL) 2025-10-22 EP claimed
EP-3648733-B1 TOPICAL COMPOSITIONS DSM IP ASSETS BV (NL) 2025-08-06 EP claimed
EP-4103288-B1 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION SYMRISE AG (DE) 2025-07-30 EP claimed
EP-3897145-B1 ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN ALCOHOL COMPOUND, AND COSMETIC COMPOSITION CONTAINING SAME OREAL (FR) 2025-06-04 EP claimed
EP-4192419-B1 EMULSIFIER COMPOSITION FOR PERSONAL CARE FORMULATION LUBRIZOL ADVANCED MAT INC (US) 2025-04-16 EP claimed
EP-0754028-B1 NOVEL DEODORISING AND ANTI-MICROBIAL COMPOSITIONS FOR USE IN COSMETIC OR TOPICAL PREPARATIONS BEIERSDORF AG (DE) 2000-09-06 EP claimed
US-6019988-A COMPOSITIONS ARE PHYSICALLY SEPARATED UNTIL APPLICATION TO A BODY OR SKIN SURFACE AND ARE TOPICALLY APPLIED, EITHER AT THE SAME TIME, OR SEQUENTIALLY WITHIN A SHORT TIME OF EACH OTHER BRISTOL-MYERS SQUIBB COMPANY (US) 2000-02-01 US claimed
EP-0540969-B1 Derivatives of structurally modified VIP and pharmaceutical compositions containing them YEDA RES & DEV (IL) 1998-12-23 EP claimed
EP-0673648-B1 Compositions comprising amphotoic salts of alpha-hydroxy acids and glycerol monocaprylate BRISTOL MYERS SQUIBB CO (US) 1998-11-25 EP claimed
EP-0613694-B1 Ophthalmic lens with anti-toxin agent JOHNSON & JOHNSON VISION PROD (US) 1998-09-16 EP claimed
EP-0857488-A2 Methods and compositions for enhancing skin permeation of drugs using permeation enhancers Bristol-Myers Squibb Company (US) 1998-08-12 EP claimed
EP-0566718-A1 STABILIZERS FOR PLASTIC MATERIALS Ciba SC Holding AG (CH) 1993-10-27 EP claimed
EP-0368339-B1 PHARMACEUTICAL PREPARATION FOR PERCUTANEOUS ADMINISTRATION CONTAINING BUNAZOSIN OR ITS SALT Eisai Co., Ltd. (JP) 1993-06-23 EP claimed
WO-1993010175-A1 STABILIZERS FOR PLASTIC MATERIALS F. HOFFMANN-LA ROCHE AG (CH) 1993-05-27 WO claimed
EP-0287036-B1 NEW PHARMACEUTICAL COMPOSITIONS COMPRISING ESTERS OR AMIDES AS ACTIVE INGREDIENTS ONO PHARMACEUTICAL CO., LTD. (JP) 1991-04-10 EP claimed